Skip to content
TrustList
Ki Foundation logo
Investor

Ki Foundation

A crypto ecosystem where holders stake a token to earn a share of fees from projects built on it

  • Business
Ki Foundation cover

About Ki Foundation

Ki Foundation runs XKI, a token described as a loyalty layer for a wider ecosystem of separate crypto projects. Holders lock, or stake, their XKI tokens for a chosen period of between three and thirty-six months, with longer lock-ups carrying a higher rewards multiplier of up to five times. Projects built on the XKI infrastructure, such as a hospitality project called Dar Society, generate their own tokens and transaction fees, a share of which is redistributed to XKI stakers in each project's own token rather than in XKI itself. The foundation frames this as an alternative to conventional equity, where users hold a stake in shared infrastructure rather than shares in a single company, and publishes a manifesto setting out this approach in more detail.

Profile written by TrustList from the business's own published information, Sep 2026.

Categories & features

  • Business

Ask TrustList to introduce you to Ki Foundation

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Ki Foundation

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Ki Foundation.

Ki Foundation alternatives

Similar listings buyers compare against this one.

Multi-stage global investment firm backing technology, healthcare and energy resilience companies

European venture capital firm backing founders building global software companies

Venture firm investing in deep tech founders who turn scientific discoveries into companies

Hong Kong alternative asset manager covering private equity, real estate, private debt and hedge funds

Stem cell and drug discovery research company supplying iPSC tools, human tissue testing and clinical services

Private equity investor in the Netherlands backing healthcare and technology companies in the Netherlands and Germany